Ginkgo Bioworks Holdings, Inc. Loss Submission Form

Company: Ginkgo Bioworks Holdings, Inc.

Ticker: (NYSE) DNA

Deadline

Passed

Lead Plaintiff Deadline: January 18, 2022

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines.

WhatsApp

WhatsApp Channel QR Code

Scan the QR code or click the button to join.

Get Updates by Email

Subscribe for email notifications.

No spam, opt-out anytime, alert list is free.

Allegations

(1) the Company’s failure to derive real revenue from third-party customers left it almost completely dependent on related parties; (2) as a result, most, if not all, of the Company’s revenue came from related parties the Company created, funded, or controlled through its ownership and board seats; (3) the Company was misclassifying and underreporting related party revenue in order to conceal the Company’s near total-dependence on related parties; (4) many of the Company’s new R&D partners are undisclosed related parties and/or façades; (5) as a result, the Company’s valuation was significant less than Defendants disclosed to investors; and (6) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.